Sirius Black
An obscure dark-leaved indica-leaning strain with minimal documentation and a name that draws more attention than the genetics.
Sirius Black is a niche strain you'll see listed at a handful of European seed banks with very little verifiable information behind it. The Harry Potter-flavored name does most of the marketing work. There's no peer-reviewed chemistry data, no consistent lineage on record, and the 'dark purple to nearly black' coloration that sellers emphasize is mostly anthocyanin expression triggered by cold nights — not a unique trait. Treat anything you read about its effects as vendor copy, not evidence. If you grow it, judge it on what you actually get.
Overview
Sirius Black is a strain sold primarily through European seed retailers, including listings on Weed Seeds Express and similar catalogs [1]. It's marketed as an indica-leaning hybrid notable mostly for very dark foliage and flowers that can express deep purple — sometimes described as 'almost black' — when grown in cool conditions. Beyond vendor listings, there is essentially no independent documentation: no peer-reviewed chemotype analysis, no breeder pedigree paperwork in public circulation, and no inclusion in major strain databases with verifiable provenance. No data
This is a strain where almost everything you'll read online traces back to seed-shop product copy. We're including it for completeness, not because there's a body of evidence to summarize.
Chemistry: cannabinoids and terpenes
No published chemotype data exists for Sirius Black. Vendor pages typically cite THC around 15–20% with negligible CBD [1], but these numbers are not backed by lab certificates that we can independently verify, and within-strain variability across grows is large in general [2]. Weak / limited
No terpene profile has been characterized in any source we can verify. Claims that dark-pigmented cannabis varieties share a specific terpene fingerprint are not supported in the literature — anthocyanin expression (responsible for purple/black coloration) is a pigment phenomenon driven by genetics interacting with temperature and pH, and it is independent of terpene biosynthesis [3]. Strong evidence
If you encounter Sirius Black flower or seed, the only reliable way to know what's in it is a third-party lab test on that specific batch.
Reported effects
There is no strain-specific clinical research on Sirius Black. None. Vendor descriptions tend to follow a standard indica template: relaxing, body-heavy, sedating in larger doses, useful for sleep [1]. Anecdote
More broadly, the idea that a strain name reliably predicts subjective effects is not well supported. Chemovar studies show that 'indica' and 'sativa' labels correlate poorly with actual cannabinoid and terpene profiles, and effects vary substantially between individuals and batches [4][5]. Strong evidence Treat any specific effect promise — 'great for anxiety,' 'will knock you out' — as folklore until you've tried it yourself at a controlled dose.
Lineage (disputed / unknown)
The parentage of Sirius Black is not publicly documented by a named breeder with a verifiable history. Some retailer pages decline to specify genetics; others give vague gestures toward Kush or 'old-school indica' ancestry [1]. We have not found a primary breeder source, a seedbank pedigree document, or a journalistic feature that establishes the cross. No data
Given the naming convention (a Harry Potter reference) and the dark-bud marketing angle, it's plausible the strain was assembled or rebranded by a retailer rather than developed by a named breeder, but we can't confirm that either. If you see confident lineage claims online for this strain, ask where the information came from.
Cultivation basics
Based on retailer descriptions, Sirius Black is grown like a typical indica-dominant hybrid: indoor flowering around 8–10 weeks, moderate stretch, manageable height [1]. To bring out the dark purple/near-black coloration that the strain is marketed for, growers report dropping nighttime temperatures during late flowering, which encourages anthocyanin accumulation in leaves and bracts [3]. Strong evidence
A few practical notes:
- Cold-induced purpling is cosmetic. It does not increase potency or change cannabinoid content in any meaningful way that's been demonstrated [3]. Strong evidence
- Yields and flowering times in vendor listings are best-case scenarios. Plan for a realistic spread.
- Without verified genetics, expect phenotype variation between seeds. Pheno-hunt if you want consistency.
For general indoor technique, see Flowering Stage and Anthocyanins if those entries are available.
Marketing vs. reality
The marketing pitch for Sirius Black leans on three things: a memorable pop-culture name, striking visual coloration, and the implicit promise that 'rare' equals 'better.' The reality is more boring:
- The color is not the chemistry. Anthocyanin pigmentation is a visual trait, not a potency or flavor indicator [3]. Strong evidence
- The name is not a lineage. Branding a strain after a fictional character tells you nothing about the genetics inside the bag.
- 'Indica' is not a prescription. The indica/sativa binary is a poor predictor of effects compared to actual cannabinoid and terpene content [4][5]. Strong evidence
- Vendor numbers are not lab numbers. THC ranges in product copy are marketing, not COAs.
None of this means Sirius Black is bad. It might be a perfectly enjoyable plant. It just means you should buy it because you want to grow a dark-flowered indica-style hybrid, not because the listing promised something specific about its effects or pedigree.
Sources
- Reported Weed Seeds Express. Sirius Black strain product listing (retailer catalog page, English sitemap).
- Peer-reviewed Jikomes N, Zoorob M. The Cannabinoid Content of Legal Cannabis in Washington State Varies Systematically Across Testing Facilities and Popular Consumer Products. Scientific Reports, 2018; 8: 4519.
- Peer-reviewed Andre CM, Hausman JF, Guerriero G. Cannabis sativa: The Plant of the Thousand and One Molecules. Frontiers in Plant Science, 2016; 7: 19.
- Peer-reviewed Smith CJ, Vergara D, Keegan B, Jikomes N. The phytochemical diversity of commercial Cannabis in the United States. PLOS ONE, 2022; 17(5): e0267498.
- Peer-reviewed Piomelli D, Russo EB. The Cannabis sativa Versus Cannabis indica Debate: An Interview with Ethan Russo, MD. Cannabis and Cannabinoid Research, 2016; 1(1): 44–46.
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.